Information XMD16-5 XMD16-5 is a novel tyrosine kinase nonreceptor 2(TNK2) inhibitor with IC50s of 16 nmol/L and 77 nmol/L for the D163E and R806Q mutations. Targets TNK2 In vitro XMD16-5 is found to be potent in the inhibition of TNK2 phosphorylation. XMD8-87 and XMD16-5 potently inhibit phosphorylation of TNK2 truncation mutations found in solid tumor types. Cell Research(from reference) Cell lines:293T cells Concentrations:10 nM-5 μM Incubation Time:6 h
All
Chemical Reagents
Biomedicine
Organic raw materials
Inorganic chemical industry
intermediate
Agricultural chemicals
Auxiliaries and catalysts
Fragrances and Flavors
Dyes and Pigments
Daily chemical industry
XMD16-5
CAS number:1345098-78-3 molecular formula:C23H24N6O2
overview
compound introduction
Specs
| Chinese alias | - | ||
| English alias | 6H-Pyrimido[4,5-b][1,4]benzodiazepin-6-one,5,11-dihydro-2-[[4-(4-hydroxy-1-piperidinyl)phenyl]amino]-11-methyl- | ||
| CAS number | 1345098-78-3 | molecular formula | C23H24N6O2 |
| molecular weight | 416.48 g/mol | Exact mass | 10mM in DMSO |
| PSA | 93.600 Ų | logp | 2.967 |
numbering system
No numbering system information yet
physicochemical properties
No physical and chemical property information yet
Safety information
No safety information yet
Production methods and uses
No production method and use information yet
Related
upstream information
No upstream information yet
downstream information
No downstream information yet
MSDS
Found 0 shareMSDS





